What We're Reading: Page 74
Industry reads hand-picked by our editors
Oct 05, 2023
-
Nature
Why rings of RNA could be the next blockbuster drug
-
Fierce Biotech
Karuna’s journey from ‘serendipitous clinical finding’ to FDA
-
FirstWord Pharma
FDA panel tips in favour of high-risk neuroblastoma therapy
-
AP News
Say goodbye to the COVID-19 vaccination card. The CDC has stopped printing them
Oct 04, 2023
Oct 03, 2023
-
Bloomberg
Novartis Weighs Selling Assets from Radiopharma Unit
-
San Francisco Business Times
Mirum’s Travere deal pays off with promising Chenodal results for CTX patients
-
FirstWord Pharma
US clears Novo Nordisk’s Rivfloza for primary hyperoxaluria type 1
-
CNN
Nobel Prize in physics won by trio who created rapid flashes of light to ‘capture the shortest of moments’
Oct 02, 2023
-
AP News
Nobel prize in medicine goes to Katalin Karikó and Drew Weissman for their work on mRNA COVID-19 vaccines
-
Axios
Conservative judge rejects pharma argument against Medicare negotiations
-
Bloomberg
Bain, Cinven Are Said to Pick Banks for €10 Billion Stada Exit
-
The Boston Globe
Broad Institute cofounder Stuart Schreiber scales back his role
Sep 29, 2023
Sep 28, 2023
-
Reuters
Biden plans $100 million drive to combat drug-resistant ‘superbugs’
-
The New England Journal of Medicine
Death of a Patient after High-Dose Gene Therapy
-
NPR
Japanese scientists pioneer potential breakthrough for infertility
Sep 27, 2023
-
Fierce Biotech
Gilead ends phase 3 leukemia trial early after data disappoint
-
Bloomberg
BioNTech Is Revising Plans for African Vaccine Factory Network
-
Stat
After a drawn out lobbying fight, ARPA-H chooses its headquarters
-
Science
Malaria cases could ebb in an even hotter world. But other diseases will get worse
Previous
